Documentos relacionados

1. Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid.
2. Dupilumab for the treatment of pembrolizumab-induced bullous pemphigoid: A case report.
3. A Systematic Review of Drug-Induced Pemphigoid.
4. A case of tripterygium glycosides-associated AGEP-like drug reaction combined with bullous pemphigoid.
5. Self-resolving bullous pemphigoid induced by cemiplimab.
6. Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature.
7. A case of nivolumab-induced bullous pemphigoid successfully treated with dupilumab.
8. Intravenous immunoglobulin for pembrolizumab-induced bullous pemphigoid-like eruption: A case report.
9. Diagnostic and therapeutic differences between immune checkpoint inhibitor-induced and idiopathic bullous pemphigoid: a cross-sectional study.
10. Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid.